Kenneth P. Aron
53Patents
8h-index
24Co-inventors
78Inventor score
Filing activity: Oct 2, 1997 → Nov 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6436052B1 | Method and system for sensing activity and measuring work performed by an individual | Human Necessities | 177 | Expired |
| US7765069B2 | Systems for the detection of short and long samples | Physics | 67 | Active |
| US6267757A | Revascularization with RF ablation | Human Necessities | 41 | Expired |
| US7177767B2 | Systems and methods for the detection of short and long samples | Physics | 34 | Expired |
| US9034656B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 12 | Active |
| US8758772B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 10 | Active |
| US8828675B2 | Peptides, devices, and methods for the detection of ehrlichia antibodies | Emerging Cross-Sectional Technologies | 9 | Active |
| US8568989B2 | Peptides and methods for the detection of Lyme disease antibodies | Emerging Cross-Sectional Technologies | 9 | Active |
| US9921218B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 8 | Active |
| US9835622B2 | Signal amplification in solution-based plasmonic specific-binding partner assays | Emerging Cross-Sectional Technologies | 8 | Active |
| US9220654B2 | Enhanced therapeutic stimulus system and methods of use | Human Necessities | 6 | Active |
| US9201071B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 6 | Active |
| US10281465B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 5 | Active |
| US10429383B2 | Signal amplification in solution-based plasmonic specific-binding partner assays | Emerging Cross-Sectional Technologies | 5 | Active |
| US10488409B2 | Signal amplification in plasmonic specific-binding partner assays | Performing Operations; Transporting | 5 | Active |
| US9157913B2 | Peptides, devices, and methods for the detection of Ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9470682B2 | Peptides, devices, and methods for the detection of Ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9651546B2 | Peptides, devices, and methods for the detection of ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9442112B2 | Compositions and methods for identifying Ehrlichia species | Emerging Cross-Sectional Technologies | 4 | Active |
| US9974476B2 | Handheld cordless non-nutritive suck assessment device | Human Necessities | 4 | Active |
| US9696300B2 | Peptides, devices, and methods for the detection of ehrlichia antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US9816987B2 | Rotors for immunoassays | Physics | 3 | Active |
| US8377643B2 | Split flow device for analyses of specific-binding partners | Physics | 3 | Active |
| US11255854B2 | Signal amplification in lateral flow and related immunoassays | Emerging Cross-Sectional Technologies | 3 | Active |
| US9766238B2 | Peptides and methods for the detection of lyme disease antibodies | Emerging Cross-Sectional Technologies | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.